Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 21 12 2019
medline: 7 7 2020
entrez: 21 12 2019
Statut: ppublish

Résumé

Hemolytic uremic syndrome (HUS), the leading cause of acute renal failure in children (< 3 years), is mainly related to Shiga toxins (Stx)-producing

Identifiants

pubmed: 31858520
doi: 10.1055/s-0039-3400301
doi:

Substances chimiques

DNA, Bacterial 0
Particulate Matter 0
Shiga Toxin 2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-120

Informations de copyright

Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

G.A. reports grants from Progetto Organizzazione non Lucrativa di Utilità Sociale–Alice Associazione per la Lotta alla Sindrome Emolitico Uremica, during the conduct of the study. M.B. reports grants from Progetto Organizzazione non Lucrativa di Utilità Sociale–Alice Associazione per la Lotta alla Sindrome Emolitico Uremica, during the conduct of the study. X.H. reports grants from USDA-ARS National Program NP108, CRIS project 2030–42000–049–00D, during the conduct of the study.

Auteurs

Maurizio Brigotti (M)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Xiaohua He (X)

Agricultural Research Service, Western Regional Research Center, U.S. Department of Agriculture, Albany, California, United States.

Domenica Carnicelli (D)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Valentina Arfilli (V)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Elisa Porcellini (E)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Elisabetta Galassi (E)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Pier Luigi Tazzari (PL)

Immunohematology and Transfusion Center, S. Orsola-Malpighi Hospital, Bologna, Italy.

Francesca Ricci (F)

Immunohematology and Transfusion Center, S. Orsola-Malpighi Hospital, Bologna, Italy.

Stephanie A Patfield (SA)

Agricultural Research Service, Western Regional Research Center, U.S. Department of Agriculture, Albany, California, United States.

Sara Testa (S)

Center for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Fabio Paglialonga (F)

Center for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Damiano Picicco (D)

Center for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Alfredo Caprioli (A)

European Reference Laboratory for Escherichia coli, Istituto Superiore di Sanità, Rome, Italy.

Gaia Scavia (G)

European Reference Laboratory for Escherichia coli, Istituto Superiore di Sanità, Rome, Italy.

Stefano Morabito (S)

European Reference Laboratory for Escherichia coli, Istituto Superiore di Sanità, Rome, Italy.

Gianluigi Ardissino (G)

Center for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH